INDSWFTLAB

IND-SWIFT LABORATORIES

Small Cap BSE: 532305 NSE: INDSWFTLAB
₹59.9
0.35 (0.59%)
As on 14 August, 2022 | 18:19

Ind-Swift Laboratories Share Price

Ind-Swift Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Ind-Swift Laboratories Share Returns

  • Over 1 Month -0.67%
  • Over 3 Month 7.09%
  • Over 6 Month -22.16%
  • Over 1 Year -20.4%

Ind-Swift Laboratories Key Statistics

P/E Ratio -329.6
PEG Ratio 3
Market Cap Cr 354
Price to Book Ratio 0.6
EPS -1.6
Dividend 0
Relative Strength Index 49.52
Money Flow Index 70.65
MACD Signal -0.04
Average True Range 2.04

Ind-Swift Laboratories Investment Rating

  • Master Rating:
  • Ind-Swift Labs. (Nse) has an operating revenue of Rs. 1,069.10 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 1% needs improvement, ROE of -0% is poor and needs improvement. The company has a high debt to equity of 141%, which can be a reason to worry. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 21 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ind-Swift Laboratories Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 272
  • 276
  • 240
  • 230
  • 242
  • 218
  • Operating Expenses Qtr Cr
  • 219
  • 241
  • 187
  • 175
  • 191
  • 177
  • Operating Profit Qtr Cr
  • 53
  • 35
  • 54
  • 55
  • 51
  • 41
  • Depreciation Qtr Cr
  • 16
  • 82
  • 21
  • 14
  • 14
  • 28
  • Interest Qtr Cr
  • 24
  • 23
  • 24
  • 24
  • 24
  • 24
  • Tax Qtr Cr
  • 0
  • 14
  • 0
  • 0
  • 0
  • 21
  • Net Profit Qtr Cr
  • 20
  • -63
  • 15
  • 24
  • 19
  • -29

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
59.7
0.15 (0.25%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 59.75
  • 50 Day
  • 60.29
  • 100 Day
  • 62.43
  • 200 Day
  • 67.54
  • 20 Day
  • 59.63
  • 50 Day
  • 59.64
  • 100 Day
  • 62.3
  • 200 Day
  • 67.63

Ind-Swift Laboratories Resistance and Support

PIVOT
₹59.89
Resistance
  • First Resistance
  • 60.67
  • Second Resistance
  • 61.79
  • Third Resistance
  • 62.57
Support
  • First Resistance
  • 58.77
  • Second Resistance
  • 57.99
  • Third Resistance
  • 56.87
  • RSI
  • 49.52
  • MFI
  • 70.66
  • MACD Single Line
  • -0.04
  • MACD
  • 0.01

Ind-Swift Laboratories Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 50,902
  • 2,429,552
  • 47.73
  • Week
  • 35,624
  • 1,909,090
  • 53.59
  • 1 Month
  • 31,263
  • 1,861,379
  • 59.54
  • 6 Month
  • 78,155
  • 4,397,763
  • 56.27

Ind-Swift Laboratories Result Highlights

Ind-Swift Laboratories Synopsis

NSE-Medical-Generic Drugs

Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 856.58 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2021. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
  • Market Cap
  • 353
  • Sales
  • 1,018
  • Shares in Float
  • 3.43
  • No of funds
  • 5
  • Yield
  • Book Value
  • 0.56
  • U/D Vol ratio
  • 1.4
  • LTDebt / Equity
  • 133
  • Alpha
  • -0.08
  • Beta
  • 0.89

Ind-Swift Laboratories

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 42%
  • 42%
  • 42%
  • Foreign Portfolio Investors
  • 0.06%
  • 0.22%
  • Individual Investors
  • 29.55%
  • 29.31%
  • 29.21%
  • Others
  • 28.45%
  • 28.63%
  • 28.57%

Ind-Swift Laboratories Management

  • Name
  • Designation
  • Mr. N R Munjal
  • Chairman & Managing Director
  • Mr. Himanshu Jain
  • Joint Managing Director
  • Mr. Rishav Mehta
  • Executive Director
  • Mr. Sahil Munjal
  • Executive Director
  • Ms. Neerja Chathley
  • Independent Director
  • Mr. S P Sharma
  • Independent Director
  • Mr. Rajinder Kumar Gupta
  • Independent Director
  • Dr. Ashwani Kumar Vig
  • Independent Director

Ind-Swift Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ind-Swift Laboratories Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-10
  • Quarterly Results
  • 2022-05-28
  • Audited Results
  • 2022-02-08
  • Quarterly Results
  • 2021-11-01
  • Quarterly Results
  • 2021-08-12
  • Quarterly Results

Ind-Swift Laboratories MF Shareholding

  • Name
  • Amount(cr)
  • Motilal Oswal S&P BSE Healthcare ETF

Ind-Swift Laboratories FAQs

What is Share Price of Ind-Swift Laboratories ?

Ind-Swift Laboratories share price is ₹59 As on 14 August, 2022 | 18:05

What is the Market Cap of Ind-Swift Laboratories ?

The Market Cap of Ind-Swift Laboratories is ₹353.9 Cr As on 14 August, 2022 | 18:05

What is the P/E ratio of Ind-Swift Laboratories ?

The P/E ratio of Ind-Swift Laboratories is -329.6 As on 14 August, 2022 | 18:05

What is the PB ratio of Ind-Swift Laboratories ?

The PB ratio of Ind-Swift Laboratories is 0.6 As on 14 August, 2022 | 18:05

Q1FY23